Was

Rogers $1M Season of Canada’s Got Talent: CGT Reveals the First Six Performers Heading to the Finale, May 14 on Citytv

Retrieved on: 
Mercredi, mai 8, 2024
Hatred, Prince Albert, Humour, ABBA, MAT, MYM, AB, CGT, Mission, Was, Kardinal Offishall, Toronto Maple Leafs, CIBC, Sterling, TROY, Lilly, Sand, Entertainment

TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- On tonight’s episode of Canada’s Got Talent on Citytv, the #CGT judges – Howie Mandel, Lilly Singh, Trish Stratus, Kardinal Offishall – and host Lindsay Ell selected the first six of eight acts moving on to the live two-hour finale, airing Tuesday, May 14 at 8 p.m. ET / 5 p.m. PT on Citytv and Citytv+. They are:

Key Points: 
  • ET / 5 p.m. PT on Citytv and Citytv+.
  • ET / 1 a.m. PT to vote two additional acts from tonight’s episode into the finale at www.Citytv.com/vote .
  • Together with Canada’s Got Talent, Rogers is committed to investing in premium original Canadian content while fostering homegrown talent.
  • Last year, Rogers contributed approximately $950M to Canadian content and produced over 12,700 hours of unique Canadian programming.

Cinesteam Uses the Wisdom of the Past to Deal With Malodorous Smells

Retrieved on: 
Mercredi, février 14, 2024
Papyrus, Pennsylvania State University, Book, Quality of life, Gold, Ebers Papyrus, Bible, Was, Business, Health care, Encyclopædia Britannica, Patient, McCormick & Company, Coffee, Cinnamon, Spice

FORT LAUDERDALE, Fla., Feb. 14, 2024 /PRNewswire/ -- Cinnamon has a long and rich reputation as a global spice. It has been recognized for its remedial properties, in particular, for millennia. In the modern era, this concept persists, with studies revealing that cinnamon can help as an antioxidant, anti-inflammatory agent, antimicrobial tool, and more. The spice also has unique physical and chemical properties that allow it to adsorb unpleasant smells — which is the inspiration for its use in Cinesteam®'s revolutionary medical device for managing wound malodors.

Key Points: 
  • Now, Cinesteam® Is Using The Spice's Unique Properties to Enhance Patient Care
    FORT LAUDERDALE, Fla., Feb. 14, 2024 /PRNewswire/ -- Cinnamon has a long and rich reputation as a global spice.
  • In the modern era, this concept persists, with studies revealing that cinnamon can help as an antioxidant, anti-inflammatory agent, antimicrobial tool, and more.
  • This is what led the team at Cinesteam® to utilize it in their innovative secondary dressing.
  • "To do so, we looked to past wisdom to glean what we could from the healers  who came before us."

New Podcast Asks Whether Justice has Been Delivered in America's Legal Battles

Retrieved on: 
Mercredi, septembre 27, 2023
Survivor, Was, LLP, New York Supreme Court, Psychological abuse, MeToo movement, Violence, Domestic violence, IHeartRadio, Government, Lissette Ochoa domestic violence case, Apple Podcasts, Google Podcasts, Bear Witness, Take Action, Divorce, Supreme court, Safe Horizon, Casino, Nursing, Spotify

NEW YORK, Sept. 27, 2023 /PRNewswire-PRWeb/ -- Dror Bikel, bestselling author, and two-time New York Divorce Trial Lawyer of the Year, will host Was Justice Delivered?, a new podcast that delves into high-stakes legal cases to find the real story behind the flashy headlines. The first two episodes of season one will be available on Sept. 27.

Key Points: 
  • add nuance to legal issues that have often been sensationalized and misunderstood," said Bikel.
  • "My guests this season provide incredible insight into the inner workings of the justice system that will make listeners question what they think they know."
  • In recognition of October being Domestic Violence Awareness Month, the first season of Was Justice Delivered?
  • If you or your client would like to be a guest on Was Justice Delivered?

Tonix Pharmaceuticals Announces Publication of Results from Phase 3 RELIEF Trial of TNX-102 SL for the Management of Fibromyalgia

Retrieved on: 
Jeudi, juin 15, 2023
Well, Was, Tonix Pharmaceuticals, Week, Safety, Sleep, American College of Rheumatology, SL, Hypoesthesia, Pain, Patient, Randomness, American College, Treatment, Fatigue, Medical imaging, Pharmaceutical industry, Fibromyalgia

CHATHAM, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced that previously disclosed results from the Phase 3 RELIEF study of TNX-102 SL for the management of fibromyalgia have been published in the peer-reviewed journal Arthritis Care & Research, an official journal of the American College of Rheumatology. In RELIEF, treatment with TNX-102 SL was associated with significant reductions in daily pain and was generally safe and well tolerated in patients with fibromyalgia. Secondary results also suggest that treatment with TNX-102 SL can improve sleep and reduce fatigue, which together with pain are recognized as core fibromyalgia symptoms. TNX-102 SL is a novel, non-opioid, centrally-acting analgesic, intended to be taken once daily at bedtime. The paper can be accessed online at https://pubmed.ncbi.nlm.nih.gov/37165930/.

Key Points: 
  • In RELIEF, treatment with TNX-102 SL was associated with significant reductions in daily pain and was generally safe and well tolerated in patients with fibromyalgia.
  • Secondary results also suggest that treatment with TNX-102 SL can improve sleep and reduce fatigue, which together with pain are recognized as core fibromyalgia symptoms.
  • TNX-102 SL is a novel, non-opioid, centrally-acting analgesic, intended to be taken once daily at bedtime.
  • Early discontinuation rates were similar for TNX-102 SL and placebo (17.7% and 16.5%, respectively).

FHC 2021 Lowered the Curtain Safely and Successfully

Retrieved on: 
Mercredi, décembre 1, 2021
Chocolate, Environmental impact of meat production, FHC, Coffee, Was, COVID-19, Dairy, Cheese, Olive oil, Beer, Condiment, Foodservice, Food, Nightclub

This is a tough year for physical shows, but FHC still welcomed 87,025 onsite audiences touring around the 200,000m2 exhibition area.

Key Points: 
  • This is a tough year for physical shows, but FHC still welcomed 87,025 onsite audiences touring around the 200,000m2 exhibition area.
  • All the prevention measures were dedicated to a FHC with zero infection, zero occurrence and zero case.
  • Meanwhile, the FHC International Chocolate Art Festival and Happy Cheese Day also brought an amazing chocolate and cheese tasting tour for visitors.
  • Other events and forums were also the unmissable parts for FHC 2021.

Baudax Bio Announces Clinical Program Update for Neuromuscular Blocking Agents BX-1000, BX-2000 and BX-3000

Retrieved on: 
Jeudi, novembre 11, 2021
Well, Safety, Primate, New Year, Was, Cornell University, National Railway Company of Belgium, Security (finance), NASDAQ, Food, Intubation, Trial of the century, Paralysis, COVID-19, NMB, Anesthesiology, Regulation of tobacco by the U.S. Food and Drug Administration, NSAID, Plasma protein binding, Neuromuscular blocking agents, Pain, Hospital, Company, U.S. Securities and Exchange Commission, GLOBE, Vital signs, Time, Patent, Feedback, Patient, FDA, Surgeon, Intellectual property, Pharmaceutical industry, Wine

MALVERN, Pa., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced a clinical program update for its neuromuscular blocking agents (NMBs), including completion of a dose-escalation study evaluating BX-1000 in healthy volunteers.

Key Points: 
  • Used together, these agents to allow a very rapid induction of neuromuscular blockade for surgical settings, followed by a rapid reversal of the neuromuscular blockade.
  • Baudax is preparing the clinical study report for this dose-escalation study and expects to submit it to FDA early in the New Year.
  • Used together, these agents allow for a very rapid induction of neuromuscular blockade for surgical settings, followed by a rapid reversal of the neuromuscular blockade.
  • These forward-looking statements are based on information currently available to Baudax Bio, and Baudax Bio assumes no obligation to update any forward-looking statements except as required by applicable law.